Bio-Rad Laboratories | BIO - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Abbott USD 3.27B 138M 2026-03
Agilent USD 476M 48M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Bio Techne USD 113.69M 2.52M 2025-12
Bio-Rad Laboratories USD 221M 14.2M 2025-12
Bruker USD 247.2M 4.7M 2025-12
Charles River Laboratories USD 196.14M 18.55M 2025-12
Danaher USD 1.86B 166M 2026-03
General Electric Aerospace USD 1.08B 496M 2026-03
Illumina USD 283M 27M 2025-12
IQVIA Holdings USD 468M 46M 2025-12
Laboratory Of America USD 538.6M 13.8M 2025-12
Merck USD 2.85B 215M 2025-12
Mettler Toledo International USD 259.83M 11.43M 2025-12
Myriad Genetics USD 122.3M 6.7M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Pacific Biosciences Of California USD 37.24M 25.68M 2025-12
Quest Diagnostics USD 504M 0 2026-03
Repligen USD 74.36M 703K 2025-12
Revvity USD 251.73M 9.82M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Siemens EUR 3.61B 489M 2025-12
Standard Biotools USD 21.55M 5.05M 2025-12
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Tosoh JPY 41.52B 2.62B 2025-12
Waters USD 240.01M 25.78M 2025-12